PTAB To Review Tyvaso Patents Despite Time-Bar Protest
The Patent Trial and Appeal Board on Thursday granted Watson Laboratories Inc.'s request to review two United Therapeutics Corp. patents covering its hypertension drug Tyvaso, turning down arguments from United Therapeutics that...To view the full article, register now.
Already a subscriber? Click here to view full article